Sun Pharma’s arm gets preliminary injunctive relief Prohibiting Biofrontera

Sun Pharmaceutical Industries’ wholly owned subsidiary — DUSA Pharmaceuticals, Inc. has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG from using DUSA’s confidential and proprietary trade secret information. Sun Pharmaceutical Industries (SPIL) is the world’s fourth largest specialty generic pharmaceutical … Read more

Sun Pharma reports consolidated net loss of Rs 219 crore in Q2

Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2018. The company has reported net loss of Rs 906.42 crore for the quarter under review, as against net profit of Rs 577.05 crore for the same quarter in the previous year. However, total income of the company increased by 4.29% at Rs … Read more

BREAKING NEWS:
“RCB’s 5 Heroes in Win Against CSK” OTT Releases This Week: Crime, Comedy & O Romeo! Royal Enfield launches new bike with premium features at lower price.